Additional antihypertensive effect of drugs in hypertensive subjects uncontrolled on diltiazem monotherapy: A randomized controlled trial using office and home blood pressure monitoring

Clinical and Experimental Hypertension

Volumn 28, Issue 7, 2006, Pages 655-662

  Karotsis, Antonis K ^a   Symeonidis, Athanasios ^a   Mastorantonakis, Stylianos E ^b   Stergiou, George S ^b  

^a Hellenic Association of General Practitioners (ELEGEIA)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Antihypertensive treatment; Combination therapy; Diltiazem; Home blood pressure; Hypertension

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIURETIC AGENT; FELODIPINE; HYDROCHLOROTHIAZIDE; LISINOPRIL; VALSARTAN;

ADD ON THERAPY; ADULT; AGED; ANKLE EDEMA; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DRUG EFFICACY; DRUG MIXTURE; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTITIONER; HOME MONITORING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; WHITE COAT HYPERTENSION;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CALCIUM CHANNEL BLOCKERS; CHLORTHALIDONE; DILTIAZEM; DRUG THERAPY, COMBINATION; FELODIPINE; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIDDLE AGED; OFFICE VISITS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 33750169510     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960600946429     Document Type: Article

References (19)

1. 2003 European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-1053.
2. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JNC 7 report. JAMA 2003;289:2560-2572.
3. 1999 World Health Organization. International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-183.
4. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-921.
5. Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, et al. Randomized trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000;356:359-365.
6. Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, et al., plus the INVEST investigators. A calcium antagonist vs. a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 2003;290:2805-2816.
7. Pool PE, Applegate WB, Woehler T, Sandall P, Cady WJ. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension. Pharmacotherapy 1993;13:487-493.
8. Thulin T, Hedner T, Gustafsson S, Olsson SO. Diltiazem compared with metoprolol as add-on therapies to diuretics in hypertension. Swedish Diltiazem-Metoprolol Multicentre Study Group. J Hum Hypertens 1991;5:107-114.
9. Manning G, Joy A, Mathias CJ, McDonald CJ, Millar-Craig MW. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension. J Hum Hypertens 1996;10:443-448.
10. Cushman WC, Cohen JD, Jones RP, Marbury TC, Rhoades RB, Smith LK. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension. Am J Hypertens 1998;11:23-30.
11. Karlberg BE, Andrup M, Oden A, for the Swedish TARKA trialists. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil, as compared to monotherapy in primary hypertension. Blood Press 2000;9:140-145.
12. Saseen JJ, Carter BL, Brown TE, Elliott WJ, Black HR. Comparison of nifedipine alone and with diltiazem or verapamil in hypertension. Hypertension 1996;28:109-114.
13. Andreyev N, Bichkov I, Skutelis A, Andreyeva T. Comparison of diltiazem, nitrendipine, and their combination for systemic hypertension and stable angina pectoris. J Cardiovasc Pharmacol 1991;18(Suppl. 9):S73-S76.
14. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T, et al., on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension Recommendations for Conventional, Ambulatory and Home Blood Pressure Measurement. J Hypertens 2003;21:821-848.
15. Stergiou G, Mengden T, Padfield P, Parati G, O'Brien E, on behalf of the Working Group on Blood Pressure Monitoring of the European Society of Hypertension. Self-blood pressure monitoring at home is an important adjunct to clinic measurements in patients with hypertension. Br Med J 2004;329;870-871.
16. Parati G, Stergiou GS. Self measured and ambulatory blood pressure in assessing the white coat phenomenon. J Hypertens 2003;21:677-682.
17. Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, et al. Reproducibility of clinic, ambulatory and home blood pressure: Implications on the design of trials for the assessment of the efficacy of antihypertensive drugs. Am J Hypertens 2001;15:101-104.
18. dabl® Educational Trust. Devices for blood pressure measurement. Available at: http://www.dableducational.org. Accessed: December 2005.
19. Liedholm H, Melander A. A placebo-controlled dose-response study of felodipine extended release in hypertensive patients. J Cardiovasc Pharmacol 1989;14:109-113.